Chronic pelvic pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Meeting the diagnostic criteria for CPP/CPPS; Having received at least one session of pelvic floor PRP injection therapy in the Pain Management Department of our hospital from June 2022 to June 2024, with complete pre-treatment and post-treatment follow-up data (follow-up time points: pre-treatment, 2 hours post-treatment, 2 weeks post-treatment, and 1 month post-treatment); Visual Analogue Scale (VAS) score or Numerical Rating Scale (NRS) score more than 3 points.
Exclusion criteria
Exclusion criteria: Excluding patients with acute or organic lesions such as acute infections, malignant tumors, and ovarian cyst torsion; Pregnant women or virgins; CPP/CPPS patients with coagulation disorders (thrombocytopenia: platelet count less than100×10^9/L, prolonged prothrombin time more than 13 seconds), severe infections (e.g., sepsis), or autoimmune diseases (e.g., systemic lupus erythematosus, requiring long-term administration of immunosuppressants); CPP/CPPS patients with allergies to autologous blood components, or those who have used antiplatelet drugs (e.g., aspirin, clopidogrel) within the recent 3 months (with drug withdrawal duration 7 days ay least) or anticoagulant drugs (e.g., warfarin, low-molecular-weight heparin) (with drug withdrawal duration 14 days at least); CPP/CPPS patients receiving other pelvic floor intervention therapies during the same period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale(VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Pelvic floor biofeedback therapy unit; | — |
Countries
China
Contacts
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine